Medicinal and
nutraceutical formulations based on Chaga mushrooms, chemical compounds and pharmaceutical compositions, and
methods of production. When administered to a human or animal, the formulations, compounds, and pharmaceutical compositions are useful for the treatment of diseases such as cancers. The
nutraceutical formulation includes a reduction of Chaga
mushroom, where the reduction is formed in a reduction
solvent; and an extraction of Chaga
mushroom, where the extraction is formed in an extraction
solvent. The reduction and extraction are mixed together or combined in accordance with methods known to those skilled in the art, to form the
nutraceutical formulation. The medicinal formulation is a
reaction product made by preparing a Chaga
mushroom reduction in a reduction
solvent under pressure, preparing a Chaga mushroom extraction in an extraction solvent, mixing or combining the Chaga reduction with the Chaga extraction, mixing or combining the Chaga formulation with an esterification mixture containing
proline,
fructose, and a
fatty acid for the development of esterified compounds, and including sources of
sugar esters capable of
emulsion within otherwise non-miscible liquid compounds, or a predetermined amount of
Manuka honey sufficient to cause esterification and facilitate
emulsion at a temperature capable of inducing a reaction between the constituents of the Chaga mushroom with the constituents of the esterification mixture or
Manuka honey, and combining that heterogenous mixture with
medium chain triglyceride oil.